BridgeBio Pharma, Inc. (BBIO)
USD 29.02
(-7.49%)
USD 29.02
(-7.49%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -607.37 Million USD | -28.72% |
| 2022 | -471.87 Million USD | 18.61% |
| 2021 | -579.74 Million USD | -22.19% |
| 2020 | -474.48 Million USD | -78.22% |
| 2019 | -266.24 Million USD | -44.96% |
| 2018 | -183.66 Million USD | -318.76% |
| 2017 | -43.85 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 3.74 Million USD | 102.11% |
| 2024 Q2 | -172.64 Million USD | -4789.79% |
| 2023 Q3 | -157.69 Million USD | -7.94% |
| 2023 Q1 | -126.16 Million USD | -3.25% |
| 2023 FY | -607.37 Million USD | -28.72% |
| 2023 Q2 | -146.09 Million USD | -15.8% |
| 2023 Q4 | -177.41 Million USD | -12.51% |
| 2022 Q3 | -129.11 Million USD | -594.39% |
| 2022 Q2 | 26.11 Million USD | 117.29% |
| 2022 Q1 | -151.01 Million USD | 8.81% |
| 2022 FY | -471.87 Million USD | 18.61% |
| 2022 Q4 | -122.18 Million USD | 5.37% |
| 2021 FY | -579.74 Million USD | -22.19% |
| 2021 Q3 | -149.49 Million USD | -59.02% |
| 2021 Q1 | -167.5 Million USD | -31.39% |
| 2021 Q2 | -94.01 Million USD | 43.87% |
| 2021 Q4 | -165.61 Million USD | -10.78% |
| 2020 Q4 | -127.48 Million USD | -6.29% |
| 2020 Q2 | -124.56 Million USD | -21.54% |
| 2020 Q1 | -102.48 Million USD | -30.33% |
| 2020 FY | -474.48 Million USD | -78.22% |
| 2020 Q3 | -119.93 Million USD | 3.72% |
| 2019 Q1 | -63.75 Million USD | 2.79% |
| 2019 FY | -266.24 Million USD | -44.96% |
| 2019 Q4 | -78.63 Million USD | -44.21% |
| 2019 Q3 | -54.53 Million USD | 21.25% |
| 2019 Q2 | -69.24 Million USD | -8.62% |
| 2018 Q3 | -41.45 Million USD | -19.18% |
| 2018 Q4 | -65.58 Million USD | -58.2% |
| 2018 Q1 | -41.83 Million USD | 0.0% |
| 2018 FY | -183.66 Million USD | -318.76% |
| 2018 Q2 | -34.78 Million USD | 16.86% |
| 2017 FY | -43.85 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -237.2 Million USD | -156.051% |
| Alkermes plc | 414.12 Million USD | 246.665% |
| Agenus Inc. | -159.54 Million USD | -280.679% |
| Aptorum Group Limited | -10.52 Million USD | -5671.652% |
| Ardelyx, Inc. | -63.27 Million USD | -859.874% |
| Dyadic International, Inc. | -8.22 Million USD | -7280.185% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | -50853.859% |
| Lantern Pharma Inc. | -17.87 Million USD | -3297.386% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | -2923.277% |
| Novavax, Inc. | -566.51 Million USD | -7.212% |
| Janux Therapeutics, Inc. | -72.97 Million USD | -732.253% |
| Pyxis Oncology, Inc. | -82.19 Million USD | -638.929% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | -3027.788% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | -5649.976% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | -1043.255% |
| Madrigal Pharmaceuticals, Inc. | -380.49 Million USD | -59.626% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -2398.786% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | -1503.871% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | -370.873% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | -623.801% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -3362.968% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | -1280.073% |
| Clearside Biomedical, Inc. | -24.84 Million USD | -2344.735% |
| C4 Therapeutics, Inc. | -139.03 Million USD | -336.859% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | -115.246% |
| AlloVir, Inc. | -181.33 Million USD | -234.951% |
| Arrowhead Pharmaceuticals, Inc. | -205 Million USD | -196.275% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1975.911% |
| Bicycle Therapeutics plc | -189.94 Million USD | -219.759% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | -253.57% |
| ChromaDex Corporation | -5.59 Million USD | -10747.83% |
| Chimerix, Inc. | -93.06 Million USD | -552.63% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | -1247.397% |
| Caribou Biosciences, Inc. | -116.05 Million USD | -423.329% |
| CRISPR Therapeutics AG | -222.53 Million USD | -172.929% |
| Precision BioSciences, Inc. | -43.73 Million USD | -1288.719% |
| Fate Therapeutics, Inc. | -190.51 Million USD | -218.811% |
| Fortress Biotech, Inc. | -142.34 Million USD | -326.698% |
| Fortress Biotech, Inc. | -142.34 Million USD | -326.698% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | -521.707% |
| ImmuCell Corporation | -5.74 Million USD | -10466.488% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | -351.815% |
| Immix Biopharma, Inc. | -16.14 Million USD | -3662.876% |
| Incyte Corporation | 620.52 Million USD | 197.88% |
| Innoviva, Inc. | 176.7 Million USD | 443.712% |
| IO Biotech, Inc. | -91.44 Million USD | -564.206% |
| Jaguar Health, Inc. | -34.29 Million USD | -1671.223% |
| Keros Therapeutics, Inc. | -169.94 Million USD | -257.401% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | 5185.999% |
| ContextLogic Inc. | -328 Million USD | -85.174% |
| MiMedx Group, Inc. | 37.11 Million USD | 1736.41% |
| MEI Pharma, Inc. | 14.54 Million USD | 4276.661% |
| NextCure, Inc. | -67.63 Million USD | -797.985% |
| Onconetix, Inc. | -36.03 Million USD | -1585.519% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | -1356.034% |
| Opthea Limited | -191.84 Million USD | -216.598% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -21971.534% |
| Vaxcyte, Inc. | -468.04 Million USD | -29.769% |
| PDS Biotechnology Corporation | -43.04 Million USD | -1311.004% |
| Precigen, Inc. | -88.92 Million USD | -583.029% |
| Pharming Group N.V. | -4.87 Million USD | -12347.27% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | -263.016% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | -1941.168% |
| PureTech Health plc | -146.19 Million USD | -315.441% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | -2864.082% |
| Avidity Biosciences, Inc. | -235.59 Million USD | -157.799% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -2398.786% |
| Sangamo Therapeutics, Inc. | -274 Million USD | -121.664% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | -1972.581% |
| Acelyrin, Inc. | -422.06 Million USD | -43.905% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | -4710042.118% |
| Summit Therapeutics Inc. | -89.73 Million USD | -576.841% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | -1538.706% |
| Senti Biosciences, Inc. | -92.72 Million USD | -555.009% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | -429.192% |
| Elevation Oncology, Inc. | -45.44 Million USD | -1236.495% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | -1672.463% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -15307.473% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | -19108.412% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | -1739.345% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -7044.689% |
| Wave Life Sciences Ltd. | -67.99 Million USD | -793.244% |
| Seer, Inc. | -103.46 Million USD | -487.041% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | -823.63% |
| Aadi Bioscience, Inc. | -71.93 Million USD | -744.355% |
| ESSA Pharma Inc. | -32.13 Million USD | -1790.11% |
| GlycoMimetics, Inc. | -39.27 Million USD | -1446.443% |
| GT Biopharma, Inc. | -13.57 Million USD | -4373.851% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | -177.058% |
| Akebia Therapeutics, Inc. | -46.25 Million USD | -1213.062% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 799.638% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -970.086% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | -1079.222% |
| Alzamend Neuro, Inc. | -9.93 Million USD | -6011.81% |
| Sorrento Therapeutics, Inc. | -504.31 Million USD | -20.435% |
| TRACON Pharmaceuticals, Inc. | -6.89 Million USD | -8705.016% |
| Viracta Therapeutics, Inc. | -50.69 Million USD | -1098.134% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | -133.911% |
| Aptose Biosciences Inc. | -52.35 Million USD | -1060.077% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | -4111.771% |
| Soligenix, Inc. | -7.69 Million USD | -7790.033% |
| Century Therapeutics, Inc. | -146.54 Million USD | -314.457% |
| Kura Oncology, Inc. | -165.8 Million USD | -266.318% |
| TScan Therapeutics, Inc. | -93.45 Million USD | -549.886% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | -7200.998% |
| Ocean Biomedical, Inc. | -2.48 Million USD | -24374.551% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | -9267.212% |
| Autolus Therapeutics plc | -195.02 Million USD | -211.427% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -617.448% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | -724.536% |
| Eterna Therapeutics Inc. | -21.13 Million USD | -2773.764% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | -167.523% |
| GRI Bio, Inc. | -11.38 Million USD | -5233.89% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -13350.14% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | -362.959% |
| IGM Biosciences, Inc. | -263.46 Million USD | -130.535% |
| INmune Bio, Inc. | -29.74 Million USD | -1942.198% |
| Heron Therapeutics, Inc. | -110.61 Million USD | -449.085% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -1495.18% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -3700.966% |
| Entero Therapeutics, Inc. | -15.77 Million USD | -3751.225% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | -894.091% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | -464.88% |
| Atara Biotherapeutics, Inc. | -276 Million USD | -120.057% |
| Coherus BioSciences, Inc. | -203.19 Million USD | -198.904% |
| Verastem, Inc. | -92.08 Million USD | -559.583% |
| Abeona Therapeutics Inc. | -47.13 Million USD | -1188.575% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | -229.832% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | -413.068% |
| Histogen Inc. | -10.64 Million USD | -5606.756% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | -3825.618% |
| Surrozen, Inc. | -45.78 Million USD | -1226.715% |
| Organovo Holdings, Inc. | -15.08 Million USD | -3926.051% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -11832.06% |
| Ovid Therapeutics Inc. | -59.28 Million USD | -924.553% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -1084.096% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | -2302.571% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | -7857.323% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | -254.6% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | -1153.655% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | -676.638% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | -3890.402% |
| Apollomics, Inc. | -54.83 Million USD | -1007.652% |
| Amarin Corporation plc | -67.58 Million USD | -798.636% |
| Mesoblast Limited | -58.79 Million USD | -933.048% |
| Turnstone Biologics Corp. | -59.03 Million USD | -928.883% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | -266.924% |
| Synaptogenix, Inc. | -8.31 Million USD | -7205.517% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | -4064.061% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | -562.41% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -12576.079% |
| Monopar Therapeutics Inc. | -8.83 Million USD | -6777.521% |
| Exelixis, Inc. | 170.88 Million USD | 455.426% |
| Better Therapeutics, Inc. | -38.26 Million USD | -1487.397% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | -291.692% |
| Apellis Pharmaceuticals, Inc. | -517.12 Million USD | -17.452% |
| NLS Pharmaceutics AG | -11.8 Million USD | -5044.124% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | -7452.563% |
| Aridis Pharmaceuticals, Inc. | -29.99 Million USD | -1925.039% |
| Gritstone bio, Inc. | -154.63 Million USD | -292.779% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -782.023% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | -3447.09% |
| Avid Bioservices, Inc. | -18.67 Million USD | -3151.794% |
| Insmed Incorporated | -709.62 Million USD | 14.41% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | -3771.117% |
| MediWound Ltd. | -15.29 Million USD | -3872.335% |
| OmniAb, Inc. | -69.41 Million USD | -774.933% |
| Alector, Inc. | -151.74 Million USD | -300.27% |
| Seres Therapeutics, Inc. | -107.98 Million USD | -462.468% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -1064.704% |
| Zai Lab Limited | -366.57 Million USD | -65.689% |
| Revance Therapeutics, Inc. | -316.77 Million USD | -91.734% |
| Aura Biosciences, Inc. | -84.99 Million USD | -614.629% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | -147.402% |
| Immunic, Inc. | -99.22 Million USD | -512.126% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | -324.265% |
| Veracyte, Inc. | -85.79 Million USD | -607.932% |
| InMed Pharmaceuticals Inc. | - USD | Infinity% |
| FibroGen, Inc. | -281.81 Million USD | -115.521% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -4174.243% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | -8717.867% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | -3131.961% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | 204.976% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | -2286.241% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | 1665.306% |
| TG Therapeutics, Inc. | 20.63 Million USD | 3043.682% |
| Galecto, Inc. | -39.9 Million USD | -1422.04% |
| Calithera Biosciences, Inc. | -42.07 Million USD | -1343.576% |
| Fortrea Holdings Inc. | 63.1 Million USD | 1062.552% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | -332.461% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | -2003.227% |
| XBiotech Inc. | -37.51 Million USD | -1519.222% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -782.023% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | -804.902% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | -462.87% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -2265.885% |
| Theravance Biopharma, Inc. | -53.29 Million USD | -1039.702% |
| Ultragenyx Pharmaceutical Inc. | -569.2 Million USD | -6.704% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | -673.799% |
| Vaxxinity, Inc. | -58.28 Million USD | -942.069% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | -485.648% |
| Gain Therapeutics, Inc. | -22.25 Million USD | -2629.368% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | -602.844% |
| NexImmune, Inc. | -29.19 Million USD | -1980.57% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | -10707.042% |
| Marker Therapeutics, Inc. | -14.58 Million USD | -4065.381% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 115.008% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | -2285.679% |
| Scopus BioPharma Inc. | -11.71 Million USD | -5084.604% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | -378.011% |
| Ainos, Inc. | -13.2 Million USD | -4499.059% |
| Pluri Inc. | -22.15 Million USD | -2641.087% |
| Prothena Corporation plc | -191.03 Million USD | -217.935% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | -340.002% |
| Celularity Inc. | -192.28 Million USD | -215.866% |
| Rallybio Corporation | -78.93 Million USD | -669.485% |
| Cue Biopharma, Inc. | -52.14 Million USD | -1064.682% |
| MeiraGTx Holdings plc | -137.06 Million USD | -343.138% |
| Omeros Corporation | -164.53 Million USD | -269.155% |
| Humacyte, Inc. | -100.04 Million USD | -507.085% |
| Immunocore Holdings plc | -59.64 Million USD | -918.24% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | -3172.644% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | -2380.783% |
| Blueprint Medicines Corporation | -486.27 Million USD | -24.902% |
| CalciMedica, Inc. | -21.87 Million USD | -2676.549% |
| Cabaletta Bio, Inc. | -74.66 Million USD | -713.515% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | -361.931% |
| Scholar Rock Holding Corporation | -171.29 Million USD | -254.575% |
| Sana Biotechnology, Inc. | -326.9 Million USD | -85.797% |
| Pulmatrix, Inc. | -14.74 Million USD | -4020.556% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | -1599.175% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | -583.467% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | -17.869% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | -799.128% |
| Cytokinetics, Incorporated | -496.2 Million USD | -22.403% |
| Eloxx Pharmaceuticals, Inc. | -34.41 Million USD | -1664.636% |
| Nutriband Inc. | -4.87 Million USD | -12366.733% |
| Protara Therapeutics, Inc. | -43.61 Million USD | -1292.635% |
| Vor Biopharma Inc. | -126.03 Million USD | -381.902% |
| Roivant Sciences Ltd. | 4.24 Billion USD | 114.318% |
| Evogene Ltd. | -26.39 Million USD | -2201.429% |
| ProKidney Corp. | -151.52 Million USD | -300.846% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -841.148% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | -7795.877% |
| CorMedix Inc. | -48.95 Million USD | -1140.599% |
| BioLineRx Ltd. | -49.69 Million USD | -1122.22% |
| Tango Therapeutics, Inc. | -114.17 Million USD | -431.973% |
| Galectin Therapeutics Inc. | -38.07 Million USD | -1495.319% |
| Atai Life Sciences N.V. | -125.47 Million USD | -384.072% |
| Renovaro Biosciences Inc. | -81.63 Million USD | -643.968% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | -646.072% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | -143.935% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -1875.83% |
| MediciNova, Inc. | -9.9 Million USD | -6034.886% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | -380.617% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -8286.24% |
| GeoVax Labs, Inc. | -26.74 Million USD | -2171.142% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | -161.995% |
| Biomea Fusion, Inc. | -126.13 Million USD | -381.524% |
| PTC Therapeutics, Inc. | -349.4 Million USD | -73.831% |
| Mereo BioPharma Group plc | -28.41 Million USD | -2037.423% |
| Cullinan Oncology, Inc. | -191.08 Million USD | -217.847% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | -164.127% |
| Absci Corporation | -115.51 Million USD | -425.793% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -2101.653% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | -438.129% |
| Dyne Therapeutics, Inc. | -242.16 Million USD | -150.811% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | -2310.581% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | -192.013% |
| Allakos Inc. | -196.05 Million USD | -209.794% |
| Imunon, Inc. | -21.03 Million USD | -2788.053% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | -448.842% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | 666.143% |
| BioAtla, Inc. | -129.68 Million USD | -368.335% |
| NLS Pharmaceutics AG | -11.8 Million USD | -5044.124% |
| Bio-Path Holdings, Inc. | -15.84 Million USD | -3733.68% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | -85.322% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | -1354.5% |
| XOMA Corporation | -41.84 Million USD | -1351.372% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | -477.145% |
| Cara Therapeutics, Inc. | -121.49 Million USD | -399.914% |
| aTyr Pharma, Inc. | -54.91 Million USD | -1005.938% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | -594.717% |
| Akero Therapeutics, Inc. | -172.87 Million USD | -251.345% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | -138.699% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | -2729.451% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | -7295.448% |
| Akari Therapeutics, Plc | -16.8 Million USD | -3514.007% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -6868247.162% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | 279.922% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -9195.5% |
| UroGen Pharma Ltd. | -65.53 Million USD | -826.773% |
| Sutro Biopharma, Inc. | -89.27 Million USD | -580.313% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -8262.509% |
| Orgenesis Inc. | -53.63 Million USD | -1032.392% |
| Entera Bio Ltd. | -8.89 Million USD | -6731.29% |
| GH Research PLC | -41.22 Million USD | -1373.412% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | -2262.572% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | -631.304% |
| Xencor, Inc. | -138.63 Million USD | -338.095% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | -11683.106% |
| Replimune Group, Inc. | -234.77 Million USD | -158.705% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | -2726.144% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | -4253.283% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -9195.5% |
| Portage Biotech Inc. | -18.25 Million USD | -3227.508% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -8286.24% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | -478.663% |
| OncoCyte Corporation | -25.13 Million USD | -2316.335% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -5272.646% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -5201.272% |
| Purple Biotech Ltd. | 22.27 Million USD | 2827.179% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | -7985.33% |
| scPharmaceuticals Inc. | -55.39 Million USD | -996.415% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | -3113.99% |
| HilleVax, Inc. | -133.34 Million USD | -355.488% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | -4940.833% |
| Tharimmune, Inc. | -9.45 Million USD | -6323.647% |
| Genprex, Inc. | -31.07 Million USD | -1854.494% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | -222.736% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | -1835.717% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | -79294.771% |
| Virios Therapeutics, Inc. | -5.44 Million USD | -11050.707% |
| OKYO Pharma Limited | -15.74 Thousand USD | -3856283.57% |
| Savara Inc. | -60 Million USD | -912.165% |
| Curis, Inc. | -48.33 Million USD | -1156.662% |
| Daré Bioscience, Inc. | -30.83 Million USD | -1869.43% |
| Carmell Therapeutics Corporation | -5.21 Million USD | -11541.507% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | -8246.434% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | -2128.881% |
| BeiGene, Ltd. | -1.2 Billion USD | 49.71% |
| Kiromic BioPharma, Inc. | -19.93 Million USD | -2946.095% |
| Revolution Medicines, Inc. Warrant | -487.18 Million USD | -24.669% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | -548.539% |
| Erasca, Inc. | -141.52 Million USD | -329.161% |
| bluebird bio, Inc. | -244.26 Million USD | -148.655% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -13316.688% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | 412.367% |
| DBV Technologies S.A. | -76.43 Million USD | -694.654% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -13316.688% |
| Moderna, Inc. | -4.23 Billion USD | 85.672% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -1325.45% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | -9449.843% |
| Molecular Templates, Inc. | -10.46 Million USD | -5703.268% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | -803.327% |
| Travere Therapeutics, Inc. | -376.74 Million USD | -61.216% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | -323.813% |
| Spruce Biosciences, Inc. | -51.99 Million USD | -1068.176% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | -293.013% |
| Cogent Biosciences, Inc. | -208.13 Million USD | -191.822% |
| MacroGenics, Inc. | -168.24 Million USD | -261.005% |
| RenovoRx, Inc. | -11.39 Million USD | -5229.677% |
| Adicet Bio, Inc. | -152.03 Million USD | -299.486% |
| Prime Medicine, Inc. | -191.29 Million USD | -217.509% |
| Aditxt, Inc. | -26.06 Million USD | -2230.443% |
| Adagene Inc. | -23.71 Million USD | -2460.596% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -8208.644% |
| Quantum-Si incorporated | -111.17 Million USD | -446.339% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | -1819.142% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -4066.413% |
| Voyager Therapeutics, Inc. | 122.01 Million USD | 597.787% |
| SciSparc Ltd. | -5.77 Million USD | -10420.873% |
| Vericel Corporation | -6.46 Million USD | -9296.194% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -6916.213% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | -2527.081% |
| Generation Bio Co. | -138.56 Million USD | -338.335% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -631.507% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | -602.487% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | -151.915% |
| Invivyd, Inc. | -207.78 Million USD | -192.31% |
| Relay Therapeutics, Inc. | -373 Million USD | -62.834% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | -6376.193% |
| Spero Therapeutics, Inc. | 21.48 Million USD | 2927.475% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -5804.248% |
| 2seventy bio, Inc. | -216.7 Million USD | -180.278% |
| ADMA Biologics, Inc. | 21.63 Million USD | 2907.739% |
| Clene Inc. | -40.54 Million USD | -1398.199% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | -2422.525% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | -1008.42% |
| GeoVax Labs, Inc. | -26.74 Million USD | -2171.142% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | -73.505% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | -1553.517% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | 3877.881% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | -485.688% |
| Finch Therapeutics Group, Inc. | -34 Million USD | -1686.277% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | -256.693% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 11.243% |
| Evaxion Biotech A/S | -22.19 Million USD | -2636.271% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | -637.261% |
| Verve Therapeutics, Inc. | -223.12 Million USD | -172.212% |
| Trevena, Inc. | -35.28 Million USD | -1621.18% |
| Surrozen, Inc. | -45.78 Million USD | -1226.715% |
| Tyra Biosciences, Inc. | -79.94 Million USD | -659.735% |
| Cingulate Inc. | -22.75 Million USD | -2568.68% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | 8206.914% |
| Unity Biotechnology, Inc. | -44.66 Million USD | -1259.773% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | -7276.419% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | -492.221% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | -727.716% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | -878.461% |
| Clearmind Medicine Inc. | -8.74 Million USD | -6848.24% |
| Kronos Bio, Inc. | -121.83 Million USD | -398.539% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | -697.115% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -20608.255% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -502.388% |
| Statera Biopharma, Inc. | -98.34 Million USD | -517.599% |
| ImmunityBio, Inc. | -362.25 Million USD | -67.666% |
| Korro Bio, Inc. | -84.53 Million USD | -618.492% |
| Kineta, Inc. | -15.72 Million USD | -3762.94% |
| BioVie Inc. | -32.17 Million USD | -1787.439% |
| Codexis, Inc. | -68.06 Million USD | -792.286% |
| Celularity Inc. | -192.28 Million USD | -215.866% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | -172.843% |
| Celcuity Inc. | -66.23 Million USD | -817.057% |
| Virax Biolabs Group Limited | -6.49 Million USD | -9249.227% |
| Cibus, Inc. | -318.88 Million USD | -90.468% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | -1312.488% |
| eFFECTOR Therapeutics, Inc. | -33.84 Million USD | -1694.616% |
| IN8bio, Inc. | -30.33 Million USD | -1902.077% |
| Kodiak Sciences Inc. | -277.32 Million USD | -119.013% |
| Annexon, Inc. | -143.72 Million USD | -322.598% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | -390.641% |
| Assembly Biosciences, Inc. | -64.64 Million USD | -839.532% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | -2490.727% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | -71.704% |
| Eyenovia, Inc. | -25.4 Million USD | -2290.614% |
| Puma Biotechnology, Inc. | 32.64 Million USD | 1960.815% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -10819.993% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | -667.531% |
| Arcellx, Inc. | -89.88 Million USD | -575.757% |
| Cardiff Oncology, Inc. | -45.41 Million USD | -1237.466% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | -342.667% |
| Regulus Therapeutics Inc. | -31.1 Million USD | -1852.393% |
| Moolec Science SA | -6.65 Million USD | -9028.161% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | -893.441% |
| Geron Corporation | -193.94 Million USD | -213.168% |
| LAVA Therapeutics N.V. | -43.25 Million USD | -1304.226% |
| Royalty Pharma plc | 1.49 Billion USD | 140.704% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | -269.982% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -6411.35% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | -2674.055% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | -255.276% |
| Humacyte, Inc. | -100.04 Million USD | -507.085% |
| Structure Therapeutics Inc. | -102.77 Million USD | -490.971% |
| 89bio, Inc. | -151.2 Million USD | -301.689% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | -657.962% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | -4077.235% |
| Genelux Corporation | -24.16 Million USD | -2413.429% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | -1690.437% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | -253.636% |
| Notable Labs, Ltd. | -14.65 Million USD | -4043.89% |
| Liquidia Corporation | -73.38 Million USD | -727.66% |
| Mustang Bio, Inc. | -50.72 Million USD | -1097.354% |
| Immunovant, Inc. | -282.7 Million USD | -114.839% |
| Quantum-Si incorporated | -111.17 Million USD | -446.339% |
| Arbutus Biopharma Corporation | -78.1 Million USD | -677.653% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | -2755.927% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -495.391% |
| Acasti Pharma Inc. | -11.31 Million USD | -5269.254% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | -2549.829% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -3700.966% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | -183.746% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | -16453.777% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -3723.304% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | -1983.102% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | -1367.645% |
| PepGen Inc. | -84.76 Million USD | -616.525% |
| Moleculin Biotech, Inc. | -29.63 Million USD | -1949.779% |
| United Therapeutics Corporation | 1.18 Billion USD | 151.259% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -2552.618% |
| Solid Biosciences Inc. | -104.31 Million USD | -482.246% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | -1751.28% |
| Immuneering Corporation | -58.41 Million USD | -939.788% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -11832.06% |
| Silo Pharma, Inc. | -3.85 Million USD | -15652.963% |
| Belite Bio, Inc | -31.66 Million USD | -1817.93% |
| XOMA Corporation | -41.84 Million USD | -1351.372% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | -799.541% |
| Bionomics Limited | -17.89 Billion USD | 96.605% |
| Apogee Therapeutics, Inc. | -93 Million USD | -553.065% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1802.27% |
| uniQure N.V. | -282.87 Million USD | -114.716% |
| Cassava Sciences, Inc. | -105.95 Million USD | -473.223% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -8208.644% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -368.997% |
| Forte Biosciences, Inc. | -32.48 Million USD | -1769.636% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | -7210.0% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | -1966.236% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -10819.993% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -4174.243% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | -6732.827% |
| Altimmune, Inc. | -95.92 Million USD | -533.145% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | -726.421% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1802.27% |
| Compugen Ltd. | -12.99 Million USD | -4574.954% |
| Peak Bio, Inc. | -1356.23 USD | -44783601.879% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | -1124.438% |
| Benitec Biopharma Inc. | -22.49 Million USD | -2600.622% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -150.665% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | -1941.854% |
| Zura Bio Limited | -62.63 Million USD | -869.651% |
| PolyPid Ltd. | -22.86 Million USD | -2556.098% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | -3631.691% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | -1941.854% |
| Instil Bio, Inc. | -159.16 Million USD | -281.588% |
| argenx SE | -425.04 Million USD | -42.894% |
| Immunome, Inc. | -109.53 Million USD | -454.524% |
| Compass Therapeutics, Inc. | -50.36 Million USD | -1105.985% |
| Verona Pharma plc | -67.83 Million USD | -795.418% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | -2230.66% |
| Shattuck Labs, Inc. | -91.95 Million USD | -560.493% |
| CervoMed Inc. | -7.81 Million USD | -7673.943% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | -730.762% |
| Plus Therapeutics, Inc. | -13.32 Million USD | -4459.493% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -1160.784% |
| Moolec Science SA | -6.65 Million USD | -9028.161% |
| Enveric Biosciences, Inc. | -16.44 Million USD | -3592.569% |
| Inovio Pharmaceuticals, Inc. | -135.22 Million USD | -349.15% |
| AnaptysBio, Inc. | -164.41 Million USD | -269.422% |
| Design Therapeutics, Inc. | -78.19 Million USD | -676.787% |
| Leap Therapeutics, Inc. | -87.04 Million USD | -597.798% |
| NeurAxis, Inc. | -6.66 Million USD | -9013.519% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | -1399.716% |
| Lumos Pharma, Inc. | -36.61 Million USD | -1558.846% |
| Achilles Therapeutics plc | -75.25 Million USD | -707.083% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | -2230.66% |
| 180 Life Sciences Corp. | -13.47 Million USD | -4406.548% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | 11879.158% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -20608.255% |
| Nutriband Inc. | -4.87 Million USD | -12366.733% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | -448.267% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | -995.367% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | -1094.764% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | -818.879% |
| MoonLake Immunotherapeutics | -54.12 Million USD | -1022.201% |
| Palisade Bio, Inc. | -13.07 Million USD | -4547.054% |
| Tourmaline Bio, Inc. | -45.4 Million USD | -1237.554% |
| Beam Therapeutics Inc. | -176.48 Million USD | -244.148% |
| Neurogene Inc. | -55.58 Million USD | -992.726% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | -456.434% |
| AEON Biopharma, Inc. | -48.42 Million USD | -1154.145% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | -528.032% |
| Sesen Bio, Inc. | -25.9 Million USD | -2244.243% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | -627.137% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | -4725.415% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | -31.877% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | -738.457% |
| Athira Pharma, Inc. | -125.46 Million USD | -384.091% |
| Vaccinex, Inc. | -22.88 Million USD | -2554.009% |
| HCW Biologics Inc. | -25.71 Million USD | -2261.73% |
| XOMA Corporation | -41.84 Million USD | -1351.372% |
| Nektar Therapeutics | -137.42 Million USD | -341.965% |
| Arvinas, Inc. | -401.5 Million USD | -51.275% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -6868247.162% |
| Merus N.V. | -156.54 Million USD | -287.979% |
| Omega Therapeutics, Inc. | -100.26 Million USD | -505.789% |
| Quince Therapeutics, Inc. | -34.62 Million USD | -1654.391% |
| Rezolute, Inc. | -70.42 Million USD | -762.46% |
| Clene Inc. | -40.54 Million USD | -1398.199% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | -3608.343% |
| BeyondSpring Inc. | -23.11 Million USD | -2527.715% |
| Synlogic, Inc. | -55.16 Million USD | -1001.086% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | -3287.64% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -5511.327% |
| Peak Bio, Inc. | -1356.23 USD | -44783601.879% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | -1399.568% |
| Krystal Biotech, Inc. | -109.72 Million USD | -453.528% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | -368.867% |
| SpringWorks Therapeutics, Inc. | -343.01 Million USD | -77.069% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | -12697.64% |
| MannKind Corporation | 8.67 Million USD | 7098.963% |
| Ikena Oncology, Inc. | -75.41 Million USD | -705.349% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | -6195.947% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | -803.421% |
| Gossamer Bio, Inc. | -183.75 Million USD | -230.525% |
| CohBar, Inc. | -12.38 Million USD | -4802.772% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | -1097.402% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -2101.653% |
| Legend Biotech Corporation | -439.48 Million USD | -38.2% |
| Mural Oncology plc | -194.63 Million USD | -212.051% |
| Biora Therapeutics, Inc. | -67.14 Million USD | -804.592% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -3661.907% |
| Disc Medicine, Inc. | -91.12 Million USD | -566.524% |
| Champions Oncology, Inc. | -7.35 Million USD | -8156.797% |
| REGENXBIO Inc. | -268.12 Million USD | -126.522% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -5566.723% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -989.336% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | -1458.932% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | -431.117% |
| Vaxart, Inc. | -83.34 Million USD | -628.724% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | -7028.749% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | -1319.285% |
| Cellectis S.A. | -106.62 Million USD | -469.627% |
| Longeveron Inc. | -21.02 Million USD | -2788.25% |
| Repare Therapeutics Inc. | -116.22 Million USD | -422.586% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | -126.78% |
| Inozyme Pharma, Inc. | -75.64 Million USD | -702.922% |
| Revolution Medicines, Inc. | -487.18 Million USD | -24.669% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | -9030.637% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | -1281.831% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -714.278% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | -772.219% |
| Anixa Biosciences, Inc. | -11.01 Million USD | -5416.029% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 114.1% |
| Denali Therapeutics Inc. | -196.69 Million USD | -208.781% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -6916.213% |
| Veru Inc. | -93.78 Million USD | -547.639% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | -2503.498% |
| Cingulate Inc. | -22.75 Million USD | -2568.68% |
| Passage Bio, Inc. | -108.38 Million USD | -460.361% |
| Context Therapeutics Inc. | -25.07 Million USD | -2322.444% |
| Exicure, Inc. | -14.99 Million USD | -3950.213% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -194.748% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | -1396.059% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | -6150.632% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | -229.453% |
| Nuvalent, Inc. | -149.49 Million USD | -306.289% |
| ABVC BioPharma, Inc. | -8.21 Million USD | -7292.069% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | -584.507% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | -2823.703% |
| OmniAb, Inc. | -69.41 Million USD | -774.933% |
| Anew Medical, Inc. | -1.3 Million USD | -46590.6% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | -4655.853% |
| Lipocine Inc. | -17.93 Million USD | -3287.27% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | -786.503% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | -697.576% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -1495.18% |
| G1 Therapeutics, Inc. | -39.52 Million USD | -1436.595% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | -2613.411% |
| Sage Therapeutics, Inc. | -579.84 Million USD | -4.746% |
| Ocugen, Inc. | -65.53 Million USD | -826.844% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | -547.061% |
| Q32 Bio Inc. | -92.1 Million USD | -559.454% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | -2733.015% |
| Alumis Inc. Common Stock | -158.17 Million USD | -283.989% |
| Equillium, Inc. | -14.52 Million USD | -4082.413% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | -873.256% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -7584.97% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -3119.542% |
| Galera Therapeutics, Inc. | -46.95 Million USD | -1193.625% |
| Evelo Biosciences, Inc. | -108.46 Million USD | -459.963% |
| Comera Life Sciences Holdings, Inc. | -11.97 Million USD | -4974.096% |
| Dominari Holdings Inc. | -21.79 Million USD | -2686.612% |
| Edesa Biotech, Inc. | -9.22 Million USD | -6485.557% |
| vTv Therapeutics Inc. | -25.5 Million USD | -2281.656% |
| Bio-Techne Corporation | 206.68 Million USD | 393.861% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | -55.144% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | 416.289% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | -359.165% |
| Candel Therapeutics, Inc. | -38.39 Million USD | -1482.064% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -301.963% |
| Nkarta, Inc. | -131.65 Million USD | -361.352% |
| BioCardia, Inc. | -11.64 Million USD | -5116.163% |
| Iterum Therapeutics plc | -47.46 Million USD | -1179.536% |